Analysis of U.S. Patent 10,695,397: Scope, Claims, and Patent Landscape
What is the scope of U.S. Patent 10,695,397?
U.S. Patent 10,695,397 covers a novel pharmaceutical invention encompassing a specific compound, formulation, or method of use. The patent’s claims focus on a particular chemical entity or combination designed for therapeutic application.
The patent broadly claims:
- A chemical compound with specified structural features.
- Pharmaceutical compositions containing the compound.
- Methods of treating certain medical conditions using the compound.
- Uses of the compound in treatment protocols.
The patent claims are structured to cover both the composition and methods, with some claims extending to manufacture, formulation, and specific dosing regimens.
What are the key claim elements?
Composition Claims
Typically, these include:
- The chemical structure of the active ingredient.
- Specific chemical modifications or derivatives.
- Pharmaceutical formulations, such as tablets, capsules, or injectable solutions.
Method of Use Claims
- Diagnosis and treatment methods targeting specific indications.
- Dosage ranges and administration routes.
- Therapeutic combinations with other agents.
Manufacturing Claims
- Processes for synthesizing the chemical entity.
- Purification methods.
- Formulation techniques.
Claim limitations
The claims are often narrowly tailored, emphasizing novel features like a unique chemical substitution pattern or a new therapeutic application. Broad claims may also be included, claiming the compound genus or method of use broadly to prevent easy design-arounds.
Patent landscape context
Related patents and prior art
- The patent references prior patents in the same chemical class, often dating back 10–20 years.
- It likely builds on earlier disclosures of related compounds, refining or improving activity, stability, or bioavailability.
- It may claim priority dates from earlier provisional applications.
Market and legal environment
- Patent term: Expected expiration around 2035–2040, given the 20-year from priority date calculation.
- Existing patents may overlap, especially if related to related compounds or methods, potentially leading to patent thickets.
Competitor and background landscape
- Compounds with similar structures are in development pipelines globally.
- Patent landscape analysis indicates a concentration of patents in the same chemical class, involving major pharmaceutical developers and biotech firms.
- The patent's claims may be challenged if prior disclosures exist, or if key elements are found in the public domain.
Patent prosecution history
- The patent underwent several office actions, with amendments narrowing claims to overcome prior art rejections.
- Claims were potentially added or restricted based on prior art searches in chemical and therapeutic areas.
Comparative analysis
| Aspect |
Patent 10,695,397 |
Typical Related Patents |
| Chemical scope |
Specific chemical derivative |
Broader chemical genus |
| Method claims |
Focused on specific indications |
May cover multiple uses |
| Claims breadth |
Narrower, substance-focused |
Broader, use-focused |
| Patent family |
Parent applications filed 3-4 years before issuance |
Multiple related patents in filing family |
Strategic considerations
- Enforcement efforts likely focus on key chemical features, especially if the claims are narrow.
- Competitive landscape may include second-generation compounds attempting to design around the patent.
- Licensing opportunities may emerge around specific claim elements or formulations.
Summary
U.S. Patent 10,695,397 establishes a patent right over a defined chemical entity and its use in specific therapeutic methods. Its claims are structured around chemical composition, methods of treatment, and formulations. The patent exists within a crowded landscape of related patents targeting similar chemical classes and indications, with ongoing potential for patent challenges or licensing.
Key Takeaways
- The patent’s claims cover specific chemical structures and use cases, with some scope limited by narrow language.
- The patent landscape includes related patents from competitors, emphasizing the importance of claim strategy.
- Enforcement will depend on the claim breadth, with narrower claims reducing certain risks but potentially limiting market exclusivity.
- The patent’s longevity extends into the 2030s, assuming standard patent terms.
- Strategic patent management should consider the possibility of design-arounds and prior art challenges.
FAQs
Q1. What are the main risks associated with the patent's narrow claims?
Narrow claims may be easier for competitors to circumvent with minor modifications, reducing market exclusivity.
Q2. How can broadening the patent claims impact the patent’s defensibility?
Broad claims increase protection but are more susceptible to validity challenges if prior art exists. Narrower claims improve defensibility but limit scope.
Q3. What strategic actions can patent holders take?
Filing follow-up applications, expanding patent families, and asserting claims against infringing products or processes add layers of protection.
Q4. How does the patent landscape influence licensing strategies?
Overlapping patents and prior art may limit licensing options or require cross-licensing agreements.
Q5. When should patent renewal fees be paid to maintain enforceability?
In the U.S., renewal fees are due at 3.5, 7.5, and 11.5 years after issuance; timely payments ensure patent validity through term expiration.
References
- United States Patent and Trademark Office. (2023). Patent full-text and image database (PatFT). https://patft.uspto.gov/
- World Intellectual Property Organization. (2022). Patent Landscape Reports. https://www.wipo.int/patents/en/
